Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-08-21 20:09 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
LAUBE, MALGORZATA IRENA
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-400,000 vol |
100,000 | |
Filed 2024-08-21 20:07 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,666,675 vol |
416,669 | |
Filed 2024-08-21 20:06 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-400,000 vol |
100,000 | |
Filed 2024-08-21 20:03 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Grabski, Janusz Bernand
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-400,000 vol |
100,000 | |
Filed 2024-08-21 19:57 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,553,280 vol |
638,320 | |
Filed 2024-08-21 19:56 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-10,000,000 vol |
2,500,000 | |
Filed 2024-08-21 19:48 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Varshney, Praveen
5 - Senior Officer of Issuer
Holder: Varshney Capital Corp. (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-268,000 vol |
67,000 | |
Filed 2024-08-21 19:47 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Varshney, Praveen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,532,000 vol |
1,133,000 | |
Filed 2024-07-26 13:55 Tx date 2024-07-26 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-3,295,388.94
-14,327,778 vol $0.23 each |
19,617,153 | |
Filed 2024-07-22 19:43 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
Varshney, Praveen
5 - Senior Officer of Issuer
Holder: Varshney Capital Corp. (Indirect Ownership)
|
Options
50 - Grant of options
|
$73,700
+335,000 vol $0.22 each |
335,000 | |
Filed 2024-07-22 19:42 Tx date 2024-02-08 |
$HBP
Helix BioPharma Corp. |
Varshney, Praveen
5 - Senior Officer of Issuer
Holder: Varshney Capital Corp. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-07-22 19:42 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
Varshney, Praveen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,246,300
+5,665,000 vol $0.22 each |
5,665,000 | |
Filed 2024-07-22 19:41 Tx date 2024-02-08 |
$HBP
Helix BioPharma Corp. |
Varshney, Praveen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-07-22 19:28 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,000
+350,000 vol $0.22 each |
500,000 | |
Filed 2024-07-22 19:25 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
LAUBE, MALGORZATA IRENA
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,000
+350,000 vol $0.22 each |
500,000 | |
Filed 2024-07-22 19:22 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
Grabski, Janusz Bernand
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$110,000
+500,000 vol $0.22 each |
500,000 | |
Filed 2024-07-22 19:22 Tx date 2023-08-21 |
$HBP
Helix BioPharma Corp. |
Grabski, Janusz Bernand
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-07-22 19:16 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,640,000
+12,000,000 vol $0.22 each |
12,500,000 | |
Filed 2023-08-25 12:35 Tx date 2023-08-21 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$500,000
+2,777,778 vol $0.18 each |
33,944,931 | |
Filed 2023-08-25 12:17 Tx date 2023-08-21 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$72,000
+400,000 vol $0.18 each |
2,083,344 | |
Filed 2023-01-10 11:47 Tx date 2023-01-09 |
$HBP
Helix BioPharma Corp. |
LAUBE, MALGORZATA IRENA
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+150,000 vol $0.26 each |
150,000 | |
Filed 2023-01-10 11:46 Tx date 2022-12-08 |
$HBP
Helix BioPharma Corp. |
LAUBE, MALGORZATA IRENA
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-01-10 11:44 Tx date 2023-01-09 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+150,000 vol $0.26 each |
150,000 | |
Filed 2023-01-10 11:43 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-01-10 11:42 Tx date 2023-01-09 |
$HBP
Helix BioPharma Corp. |
Maciejewski, Krzysztof (Christopher)
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+150,000 vol $0.26 each |
150,000 | |
Filed 2023-01-10 11:41 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Maciejewski, Krzysztof (Christopher)
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-01-10 11:38 Tx date 2023-01-09 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$130,000
+500,000 vol $0.26 each |
500,000 | |
Filed 2023-01-10 11:35 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-11-21 11:38 Tx date 2022-05-18 |
$HBP
Helix BioPharma Corp. |
KAWAR, HATEM
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-11-08 10:31 Tx date 2022-11-03 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$198,000
+1,100,000 vol $0.18 each |
3,191,600 | |
Filed 2022-11-08 10:17 Tx date 2022-11-03 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$72,000
+400,000 vol $0.18 each |
1,683,344 | |
Filed 2022-04-28 11:35 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Maciejewski, Krzysztof (Christopher)
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
680,036 | ||
Filed 2022-04-28 11:27 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,555,500 | ||
Filed 2022-04-28 11:27 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,091,600 | ||
Filed 2022-04-27 12:57 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,283,344 | ||
Filed 2022-04-25 12:29 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
627,500 | ||
Filed 2022-04-22 14:42 Tx date 2022-04-22 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,002,000
+7,700,000 vol $0.26 each |
31,167,153 | |
Filed 2022-03-15 17:53 Tx date 2022-03-11 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,001,000
+3,850,000 vol $0.26 each |
23,467,153 | |
Filed 2020-09-04 11:07 Tx date 2020-08-27 |
$HBP
Helix BioPharma Corp. |
CAIAC Fund Management AG (on behalf of Biotech Opportunity Fund - HBP Fund)
3 - 10% Security Holder of Issuer
Holder: Biotech Opportunity Fund - HBP Fund (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$13,181,586
+26,363,172 vol $0.50 each |
26,363,172 | |
Filed 2020-09-04 11:05 Tx date 2020-08-27 |
$HBP
Helix BioPharma Corp. |
CAIAC Fund Management AG (on behalf of Biotech Opportunity Fund - HBP Fund)
3 - 10% Security Holder of Issuer
Holder: Biotech Opportunity Fund - HBP Fund (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-17 13:27 Tx date 2020-08-11 |
$HBP
Helix BioPharma Corp. |
Majewski, Slawomir
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+550,000 vol |
1,150,000 | |
Filed 2020-08-17 13:24 Tx date 2020-08-11 |
$HBP
Helix BioPharma Corp. |
Fafara, Ireneusz Jan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,000,000 | |
Filed 2020-08-17 13:22 Tx date 2020-08-11 |
$HBP
Helix BioPharma Corp. |
Gabor, Artur Benedykt
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,000,000 | |
Filed 2019-12-12 18:05 Tx date 2019-12-12 |
$HBP
Helix BioPharma Corp. |
Fafara, Ireneusz Jan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
Filed 2019-12-12 18:04 Tx date 2019-10-09 |
$HBP
Helix BioPharma Corp. |
Fafara, Ireneusz Jan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-12-12 17:45 Tx date 2019-12-12 |
$HBP
Helix BioPharma Corp. |
Majewski, Slawomir
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
600,000 | |
Filed 2019-12-12 17:44 Tx date 2019-12-12 |
$HBP
Helix BioPharma Corp. |
Gabor, Artur Benedykt
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
Filed 2019-08-22 19:26 Tx date 2019-08-21 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+13,725,500 vol |
17,659,500 | |
Filed 2019-08-22 19:23 Tx date 2019-08-21 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
3,934,000 | ||
Filed 2019-08-22 19:23 Tx date 2019-08-21 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$6,245,102
+13,725,500 vol $0.455 each |
19,617,153 | |
Filed 2019-08-22 19:21 Tx date 2019-08-21 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,891,653 | ||
Filed 2019-05-30 16:18 Tx date 2019-05-27 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$765,000
+1,500,000 vol $0.51 each |
1,500,000 | |
Filed 2019-05-30 15:53 Tx date 2019-05-27 |
$HBP
Helix BioPharma Corp. |
Cacek, Sylwester, Eugeniusz
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
Filed 2019-05-29 10:25 Tx date 2018-11-01 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-33,500
-25,000 vol $1.34 each |
0 | |
Filed 2019-05-29 09:43 Tx date 2019-05-27 |
$HBP
Helix BioPharma Corp. |
Majewski, Slawomir
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
350,000 | |
Filed 2019-05-29 09:41 Tx date 2019-05-27 |
$HBP
Helix BioPharma Corp. |
Gabor, Artur Benedykt
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
Filed 2019-05-29 09:34 Tx date 2019-02-07 |
$HBP
Helix BioPharma Corp. |
Gabor, Artur Benedykt
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-28 15:41 Tx date 2019-05-27 |
$HBP
Helix BioPharma Corp. |
Chao, Heman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,020,000
+2,000,000 vol $0.51 each |
2,625,000 | |
Filed 2018-03-21 Tx date 2016-12-17 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-420,000
-250,000 vol $1.68 each |
25,000 | |
Filed 2018-03-21 Tx date 2015-08-17 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-243,000
-100,000 vol $2.43 each |
425,000 | |
Filed 2018-03-21 Tx date 2015-08-17 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
55 - Expiration of warrants
|
$-243,000
-100,000 vol $2.43 each |
||
Filed 2018-03-21 Tx date 2014-12-14 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-274,000
-100,000 vol $2.74 each |
525,000 | |
Filed 2018-03-21 Tx date 2016-07-29 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, PHOTIOS
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-450,000
-150,000 vol $3.00 each |
275,000 | |
Filed 2017-07-31 Tx date 2017-07-26 |
$HBP
Helix BioPharma Corp. |
orlowski, marek jan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,500
-5,000 vol $0.90 each |
1,673,500 | |
Filed 2017-07-31 Tx date 2017-07-25 |
$HBP
Helix BioPharma Corp. |
orlowski, marek jan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,350
-31,500 vol $0.90 each |
1,678,500 | |
Filed 2016-04-28 Tx date 2016-04-20 |
$HBP
Helix BioPharma Corp. |
Demas, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
Filed 2016-04-28 Tx date 2016-04-20 |
$HBP
Helix BioPharma Corp. |
Demas, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-04-28 Tx date 2016-04-20 |
$HBP
Helix BioPharma Corp. |
Demas, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2015-11-16 Tx date 2015-11-11 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, FRANK
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,195
-6,500 vol $2.03 each |
0 | |
Filed 2015-11-12 Tx date 2012-03-16 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-12 Tx date 2012-03-12 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-12 Tx date 2012-03-16 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-12 Tx date 2012-03-12 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-12 Tx date 2012-03-12 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-12 Tx date 2012-03-16 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-10 Tx date 2015-11-06 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, FRANK
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,000
-10,000 vol $2.00 each |
6,500 | |
Filed 2015-09-11 Tx date 2015-09-08 |
$HBP
Helix BioPharma Corp. |
Demas, Steve
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,300
-5,000 vol $2.06 each |
0 | |
Filed 2015-05-13 Tx date 2015-05-08 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+60,000 vol $2.00 each |
435,000 | |
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Wills, Stacy Lee
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$28,490
+18,500 vol $1.54 each |
18,500 | |
Filed 2015-05-01 Tx date 2013-06-12 |
$HBP
Helix BioPharma Corp. |
Wills, Stacy Lee
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Wills, Stacy Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,350
+18,500 vol $1.10 each |
18,500 | |
Filed 2015-05-01 Tx date 2013-06-12 |
$HBP
Helix BioPharma Corp. |
Wills, Stacy Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+18,500 vol |
68,500 | |
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Verhagen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,350
+18,500 vol $1.10 each |
85,900 | |
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, FRANK
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$25,410
+16,500 vol $1.54 each |
16,500 | |
Filed 2015-05-01 Tx date 2005-06-01 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, FRANK
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, FRANK
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$18,150
+16,500 vol $1.10 each |
16,500 | |
Filed 2015-05-01 Tx date 2005-06-01 |
$HBP
Helix BioPharma Corp. |
MICHALARGIAS, FRANK
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Demas, Steve
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$7,700
+5,000 vol $1.54 each |
10,000 | |
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Demas, Steve
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,500
+5,000 vol $1.10 each |
5,000 | |
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,700
+5,000 vol $1.54 each |
5,000 | |
Filed 2015-05-01 Tx date 2013-12-18 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2013-12-18 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,500
+5,000 vol $1.10 each |
5,000 |